We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab vs Dacarbazine in Metastatic Melanoma

This study has been terminated.
(Lack of financing of the study drug. Not sufficient financial support.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01705392
First Posted: October 12, 2012
Last Update Posted: February 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
The Norwegian Melanoma Group
Norwegian Cancer Society
Information provided by (Responsible Party):
Haukeland University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 20, 2017
  Primary Completion Date: February 20, 2017 (Final data collection date for primary outcome measure)